Biocompatibility Testing Services Market: By Type and Region Forecast 2020-2031

Biocompatibility Testing Services Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Material Characterization, Cytotoxicity, Hemocompatibility, Implantation Testing, Intracutaneous Reactivity, Sensitization, Systemic Toxicity, Pyrogenecity, and USP Plastics) and Region Forecast 2020-2031

Biocompatibility Testing Services Market size was valued at US$ 9.8 billion in 2024 and is expected to reach US$ 18.4 billion by 2031, growing at a significant CAGR of 9.4% from 2025-2031. Due to increase in the research for the discovery of various types of medical devices. Moreover, due to the prevalence of various life threatening diseases, various new drugs and new devises are coming into the market those new products or devices need to be compatible with the human body, plastics and other polymers intended for use in medical devices, implants or other systems associated with a medical process, must be shown to be compatible with the human body these are the major factors that are driving the growth of the market over the forecast timeframe. An increase in the prevalence of various diseases such as cardiovascular diseases is a key factor drive.

According to World Health Organization, approximately 17.9 Mn death occurred due to cardiovascular diseases around the globe represents 31% of deaths around the globe and many people in developed countries are using heart stents and other medical devices to extend their lives for few more years. Moreover, these medical devices which are implanted in the human body must be biocompatible and the material that they use to make these devices like plastics, polymers also need to be biocompatible otherwise serious adverse effects may occur which may cause in death of the patient so biocompatibility testing should be performed and the raise in funding for the R&D activities by public and private sectors are anticipated to propel the market over the forecast years.

Global Biocompatibility Testing Services Market Summary

Study Period

2025-2031

Base Year

2024

CAGR

9.4%

Largest Market

Asia-Pacific

Fastest Growing Market

North-America

Global Biocompatibility Testing Services Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2025-2031

Market Size in 2024

US$ 9.8 billion

Market Size in 2031

US$ 18.4 billion

Market CAGR

9.4%

By Type

  • Material Characterization,
  • Cytotoxicity,
  • Hemocompatibility,
  • Implantation Testing,
  • Intracutaneous Reactivity,
  • Sensitization,
  • Systemic Toxicity,
  • Pyrogenecity, and
  • USP Plastics

By Region

  • North America (USA, Canada)
  • Europe (Germany, UK, France, Spain, Italy , Rest of Europe)
  • The Asia Pacific (China, India, Japan, Australia, South Korea, Rest of Asia- Pacific)
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
  • MEA (Saudi Arabia, UAE, South Africa, Rest of MEA)

Key Features of the Report

  • The biocompatibility testing services market report provides granular level information about the market size, regional market share, historic market (2020-2024), and forecast (2025-2031)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis  

Download Free Sample Report

Frequently Asked Questions

Biocompatibility testing services market size was valued at US$ 9.8 billion in 2024 and is expected to reach US$ 18.4 billion by 2031, growing at a significant CAGR of 9.4% from 2025-2031.

The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

The market key players Wickham Laboratories, North American Science Associates Inc., GLR Laboratories Pvt Ltd., Accuprec Research Labs Pvt. Ltd., Nelson Laboratories, Inc., Toxikon, Inc., Pacific BioLabs BioComp Laboratories, Inc., Morulaa HealthTech Pvt. Ltd., Geneva Laboratories.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Biocompatibility Testing Services Market Introduction 
2.1.Global Biocompatibility Testing Services Market  - Taxonomy
2.2.Global Biocompatibility Testing Services Market  - Definitions
2.2.1.Type
2.2.2.Region
3.Global Biocompatibility Testing Services Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Biocompatibility Testing Services Market Analysis, 2020 - 2024 and Forecast 2025 - 2031
4.1.  Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Biocompatibility Testing Services Market  By Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
5.1. Material Characterization,
5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Cytotoxicity,
5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Hemocompatibility,
5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Implantation Testing,
5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Intracutaneous Reactivity,
5.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Sensitization,
5.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Systemic Toxicity,
5.7.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
5.8. Pyrogenecity, and
5.8.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.8.3. Market Opportunity Analysis 
5.9. USP Plastics
5.9.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.9.3. Market Opportunity Analysis 
6.Global Biocompatibility Testing Services Market  By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
6.1. North America
6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Europe
6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Asia Pacific (APAC)
6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Middle East and Africa (MEA)
6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Latin America
6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.North America Biocompatibility Testing Services Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
7.1. Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
7.1.1.Material Characterization,
7.1.2.Cytotoxicity,
7.1.3.Hemocompatibility,
7.1.4.Implantation Testing,
7.1.5.Intracutaneous Reactivity,
7.1.6.Sensitization,
7.1.7.Systemic Toxicity,
7.1.8.Pyrogenecity, and
7.1.9.USP Plastics
7.2.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
7.2.1.United States of America (USA)
7.2.2.Canada
8.Europe Biocompatibility Testing Services Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
8.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Material Characterization,
8.1.2.Cytotoxicity,
8.1.3.Hemocompatibility,
8.1.4.Implantation Testing,
8.1.5.Intracutaneous Reactivity,
8.1.6.Sensitization,
8.1.7.Systemic Toxicity,
8.1.8.Pyrogenecity, and
8.1.9.USP Plastics
8.2.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Germany
8.2.2.France
8.2.3.Italy
8.2.4.United Kingdom (UK)
8.2.5.Spain
9.Asia Pacific (APAC) Biocompatibility Testing Services Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
9.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Material Characterization,
9.1.2.Cytotoxicity,
9.1.3.Hemocompatibility,
9.1.4.Implantation Testing,
9.1.5.Intracutaneous Reactivity,
9.1.6.Sensitization,
9.1.7.Systemic Toxicity,
9.1.8.Pyrogenecity, and
9.1.9.USP Plastics
9.2.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.China
9.2.2.India
9.2.3.Australia and New Zealand (ANZ)
9.2.4.Japan
9.2.5.Rest of APAC
10.Middle East and Africa (MEA) Biocompatibility Testing Services Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
10.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Material Characterization,
10.1.2.Cytotoxicity,
10.1.3.Hemocompatibility,
10.1.4.Implantation Testing,
10.1.5.Intracutaneous Reactivity,
10.1.6.Sensitization,
10.1.7.Systemic Toxicity,
10.1.8.Pyrogenecity, and
10.1.9.USP Plastics
10.2.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.GCC Countries
10.2.2.South Africa
10.2.3.Rest of MEA
11.Latin America Biocompatibility Testing Services Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
11.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Material Characterization,
11.1.2.Cytotoxicity,
11.1.3.Hemocompatibility,
11.1.4.Implantation Testing,
11.1.5.Intracutaneous Reactivity,
11.1.6.Sensitization,
11.1.7.Systemic Toxicity,
11.1.8.Pyrogenecity, and
11.1.9.USP Plastics
11.2.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Brazil
11.2.2.Mexico
11.2.3.Rest of LA
12. Competition Landscape
12.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
12.2.1.Wickham Laboratories
12.2.2.North American Science Associates Inc.,
12.2.3.GLR Laboratories Pvt Ltd.,
12.2.4.Accuprec Research Labs Pvt. Ltd.
12.2.5.Nelson Laboratories, Inc.
12.2.6.Toxikon, Inc.
12.2.7.Pacific BioLabs
12.2.8.BioComp Laboratories, Inc.,
12.2.9.Morulaa HealthTech Pvt. Ltd.
12.2.10.Geneva Laboratories
13. Research Methodology 
14. Appendix and Abbreviations 

Key Market Players

  • Wickham Laboratories
  • North American Science Associates Inc.,
  • GLR Laboratories Pvt Ltd.,
  • Accuprec Research Labs Pvt. Ltd.
  • Nelson Laboratories, Inc.
  • Toxikon, Inc.
  • Pacific BioLabs
  • BioComp Laboratories, Inc.,
  • Morulaa HealthTech Pvt. Ltd.
  • Geneva Laboratories

Related Industry Reports